Antidepressive Agents, Second-Generation

Antidepressive Agents, Second-Generation

Item
http://www.wikidata.org/entity/Q50430246
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionSerotonin Transporter Genetic Variation and Amygdala Responses to Antidepressant Medications in Major DepressionA Prediction Study of Multiple Indexes of the Effect of Different Mechanisms of Antidepressants Treatment on DepressionFecal Microbiota Transplantation for Irritable Bowel SyndromeTranscranial Magnetic Stimulation Study of Cortical Excitability as Marker of Antidepressant Response: EXCIPSY StudyGustatory Dysfunction Among a Sample of Depressed Egyptian Adults Under Anti-depressants TherapyAntidepressant Therapy for Bipolar II Major DepressionStudy of the Effects of an Antidepressant Medication and Placebo on the Brain Functioning of Normal SubjectsAripiprazole Augmentation of Antidepressants in PTSDSerotonin Transporter Genetic Variation and Amygdalar Activation Correlates of Antidepressant ResponsePre-Treatment Positron Emission Topography Scanning for Increasing Success in Antidepressant TreatmentExcessive Sweating Caused by Antidepressants: Measurement and Treatment With TerazosinAugmentation of the Antidepressant Action of Sertraline With Triiodothyronine (T3)and Reboxetine: Clinical Efficacy, Adverse Effects and Predictors of Response.PACEPro - Mood Management PilotSafety and Antidepressant Effects of Rellidep in Major Depressive DisorderStudy of Sildenafil for Treatment of SSRI-Antidepressant Sexual Dysfunction in WomenThe Antidepressant Efficacy of the Anticholinergic ScopolamineAntidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed PatientsA Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major DepressionCarcinogenicity Study of BupropionTibolone and Placebo in Adjunct to Antidepressant Medication for Women With Menopausal DepressionSafety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive DisorderUse of Multiple Brain Imaging Modalities (PET and MRS) to Identify Metabolic Abnormalities in Major DepressionIloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and IrritabilityRisk Factors for AD-Associated Switch to ManiaMagnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive DisorderARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant TreatmentCognitive-Behavioral Therapy (CBT) in Women Discontinuing Antidepressant for PregnancyStudy of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive DisorderNeuroimaging Predictors of Antidepressant Treatment OutcomeComparison of Depression Identification After Acute Coronary Syndrome: Quality of Life and Cost OutcomesAntidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older AdultsNeural and Antidepressant Effects of PropofolChronic Low Back Pain Research ProjectDeterminants in Antidepressant OutcomesHormone and Sleep Response to Antidepressant Treatment in Adolescents and Adults With DepressionRapid Antidepressant Effects of Ketamine in Major DepressionGabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone TherapyStudy of Antidepressants in Parkinson's DiseaseComponents of Placebo Effects in Sadness
P4844
Q61862274-745FD740-9F0C-40E0-8CC7-1DF30E10CEDDQ61894254-36E9957C-0039-428A-A164-C0A409F8A43CQ61902365-E82417E7-FB35-420C-8AE2-C6B268012154Q61905065-D9A1BBED-4F1E-4DD5-9100-9E82E100C7B6Q61907182-884ABA96-AD72-4376-9654-1334B25CB383Q61907842-9F34DD5D-DAD3-40EB-A66A-A9F3295E58A1Q61914776-61C2B26B-BA4D-49DB-B631-D07C37EF6076Q61915527-EEC7B17C-B807-4B9C-B71D-27C2315679FAQ61918106-601957A4-F3B8-4DE9-8709-C07CF9172A6AQ61920551-098A1D2F-BDFE-403C-8574-17A6C6EDD721Q61920584-6C8579BC-014B-41A0-B3EA-7D73BDA6DA26Q61921286-E75BA111-9679-46A5-934E-49334F1AC865Q61921878-13794529-D753-40D1-B8D4-952B89DEBD3BQ61922426-C70198AC-5E22-47F3-AF08-B856727D40E7Q61924398-B073B542-5832-4D6C-B817-8DAC8A39B0F3Q61932362-04E0637D-0BEC-445B-937D-632CC3A05B7FQ61933441-471D87EE-33B2-41E3-8669-E873EC29216BQ61933467-D69C5DD6-238F-4736-8970-C992D19BB675Q61936338-09F3E0D2-A1A6-45EF-A63E-72FA25D4A935Q61938013-59370E31-9C5A-4295-9570-30682125FB14Q61955688-11AE9A41-F8C0-4682-969C-284EC08192B9Q61955802-9625176D-236F-458A-9946-5FD94B088D49Q61956607-EE971497-F906-4DC0-AAE9-063DFA1E2997Q61956781-F5AEA647-DAA7-40FA-96BF-96FC0BC9FDDAQ61957403-42B9810B-F508-4863-A257-28BD744F78A6Q61965722-BF25DEAB-9569-4857-822B-2F7E6B71B936Q61965944-CACED655-0011-4125-9DF2-CB1B4D081277Q61966954-FA20627C-DCDA-46A9-9BD8-154656B78C24Q61967900-47B74AF8-A40B-412A-BE26-63129A330F33Q61969268-60EC42D4-CF87-4795-BDFB-D7DD997FADA4Q61969892-B9D6CA54-C655-4F8E-BC98-C47B89ACB9E5Q61975132-9BDCDB83-955E-40E2-9BB2-DE96D88DB5BFQ62054658-7C61C4E0-0E19-4756-B94D-831880E00657Q62105448-CB644D34-DCA4-4B06-BDE1-5B8834F3AA4BQ62105539-8A6E5D99-49D7-433A-80DA-727316CD5264Q62105724-32607A16-EBA3-40CD-81DB-F541895B1082Q62110158-A462C4E6-D8B6-474E-929F-F327DA66C910Q62110412-ECE2009C-04E5-4EF9-BA5E-DB549A628CC1Q62110548-F31E87D3-DC83-498E-8EC4-A3DCA2A865FBQ62822245-F0EACA29-806C-480D-BDEA-1812738D9E71
P4844

Antidepressive Agents, Second-Generation

Item
http://www.wikidata.org/entity/Q50430246
description
A structurally and mechanistic ...... inhibiting serotonin reuptake
@en
name
Antidepressive Agents, Second-Generation
@en
annangenerasjons antidepressivum
@nn
type
label
Antidepressive Agents, Second-Generation
@en
annangenerasjons antidepressivum
@nn
altLabel
Antidepressants, Atypical
@en
Antidepressive Drugs, Second-Generation
@en
Atypical Antidepressants
@en
Second-Generation Antidepressive Agents
@en
annangenerasjons antidepressiva
@nn
prefLabel
Antidepressive Agents, Second-Generation
@en
annangenerasjons antidepressivum
@nn
P279
P486
P672
P486
P672
P279
P486
P672
D27.505.954.427.700.122.050